Percutaneous Coronary Intervention for Myocardial Infarction with Left Ventricular Dysfunction

American Journal of Cardiology

Volumn 102, Issue 5 SUPPL., 2008, Pages 38G-41G

  Flaherty, James D ^a   Davidson, Charles J ^a   Faxon, David P ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DOBUTAMINE; FIBRINOLYTIC AGENT; PACLITAXEL; RAPAMYCIN;

ANGINA PECTORIS; ARTICLE; BARE METAL STENT; CARDIOGENIC SHOCK; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DRUG ELUTING STENT; FIBRINOLYTIC THERAPY; HEART ASSIST DEVICE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT; STROKE; THROMBOSIS;

EID: 50949086856     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.06.009     Document Type: Article

References (32)

1. Pfeffer M.A., Braunwald E., Moyé L.A., Basta L., Brown Jr. E.J., Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G.C., et al., SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 327 (1992) 669-677
2. Volpi A., De Vita C., Franzosi M.G., Geraci E., Maggioni A.P., Mauri F., Negri E., Santoro E., Tavazzi L., Tognoni G., and Ad Hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. Circulation 88 (1993) 416-429
3. Velazquez E.J., Pfeffer M.A., McMurray J.V., Maggioni A.P., Rouleau J.-L., Van de Werf F., Kober L., White H.D., Swedberg K., Leimberger J.D., et al., VALIANT Investigators. VALsartan In Acute myocardial iNfarcTion trial: baseline characteristics in context. Eur J Heart Fail 5 (2003) 537-544
4. Steg P.G., Dabbous O.H., Feldman L.J., Cohen-Solal A., Aumont M.-C., Lopez-Sendon J., Budaj A., Goldberg R.J., Klein W., Anderson Jr. F.A., and Global Registry of Acute Coronary Events Investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 109 (2004) 494-499
5. Ottervanger J.P., van't Hof A.W.J., Reiffers S., Hoorntje J.C.A., Suryapranata H., de Boer M.J., and Zijlstra F. Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 22 (2001) 785-790
6. Ross A.M., Coyne K.S., Moreyra E., Reiner J.S., Greenhouse S.W., Walker P.L., Simoons M.L., Draoui Y.C., Califf R.M., Topol E.J., Van de Werf F., Lundergan C.F., and GUSTO-I Angiographic Investigators. Extended mortality benefit of early postinfarction reperfusion. Circulation 97 (1998) 1549-1556
7. Stenestrand U., Lindback J., Wallentin L., and RIKS-HIA Registry. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 296 (2006) 1749-1756
8. Zijlstra F., Hoorntje J.C.A., de Boer M.J., Reiffers S., Miedema K., Ottervanger J.P., van't Hof A.W.J., and Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341 (1999) 1413-1419
9. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
10. Sheiban I., Fragasso G., Rosano G.M.C., Dharmadhikari A., Tzifos V., Pagnotta P., Chierchia S.L., and Trevi G. Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 38 (2001) 464-471
11. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neill W.W., Schaff H.V., Whitlow P.L., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: summary article. J Am Coll Cardiol 47 (2006) 216-235
12. Hasdai D., Topol E.J., Califf R.M., Berger P.B., and Holmes Jr. D.R. Cardiogenic shock complicating acute coronary syndromes. Lancet 356 (2000) 749-756
13. Hochman J.S., Sleeper L.A., White H.D., Dzavik V., Wong S.C., Menon V., Webb J.G., Steingart R., Picard M.H., Menegus M.A., et al., SHOCK Investigators. One-year survival following early revascularization for cardiogenic shock. JAMA 285 (2001) 190-192
14. Puma J.A., Sketch Jr. M.H., Thompson T.D., Simes R.J., Morris D.C., White H.D., Topol E.J., and Califf R.M. Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. Am J Cardiol 83 (1999) 482-487
15. Rott D., Behar S., Hod H., Feinberg M.S., Boyko V., Mandelzweig L., Kaplinsky E., Gottlieb S., and Argatroban in Acute Myocardial Infarction-2 (AGAMI-2) Study Group. Improved survival of patients with acute myocardial infarction with significant left ventricular dysfunction undergoing invasive coronary procedures. Am Heart J 141 (2001) 267-276
16. Patel T.N., Bavry A.A., Kumbhani D.J., and Ellis S.G. A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis. Am J Cardiol 97 (2006) 1685-1690
17. Hochman J.S., Lamas G.A., Buller C.E., Dzavik V., Reynolds H.R., Abramsky S.J., Forman S., Ruzyllo W., Maggioni A.P., White H., et al., Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355 (2006) 2395-2407
18. Clappers N., and Verheugt F.W.A. Hotline session of the 28th European Congress of Cardiology/World Congress of Cardiology 2006. Eur Heart J 27 (2006) 2896-2899
19. Erne P., Schoenenberger A.W., Burckhardt D., Zuber M., Kiowski W., Buser P.T., Dubach P., Resink T.J., and Pfisterer M. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 297 (2007) 1985-1991
20. Bavry A.A., Kumbhani D.J., Rassi A.N., Bhatt D.L., and Askari A.T. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 48 (2006) 1319-1325
21. Khot U.N., Jia G., Moliterno D.J., Lincoff A.M., Khot M.B., Harrington R.A., and Topol E.J. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA 290 (2003) 2174-2181
22. Rott D., Behar S., Leor J., Hod H., Boyko V., Mandelzweig L., and Gottlieb S. Effect on survival of acute myocardial infarction in Killip classes II or III patients undergoing invasive coronary procedures. Am J Cardiol 88 (2001) 618-623
23. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.-C., Colombo A., Schamparet E., Grube E., Kirtane A.J., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
24. Nordmann A.J., Briel M., and Bucher H.C. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27 (2006) 2784-2814
25. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
26. Eisenstein E.L., Anstrom K.J., Kong D.F., Shaw L.K., Tuttle R.H., Mark D.B., Kramer J.M., Harrington R.A., Matchar D.B., Kandzari D.E., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
27. Baks T., van Geuns R.-J., Biagini E., Wielopolski P., Mollet N.R., Cademartiri F., Boersma E., van der Giessen W.J., Krestin G.P., Duncker D.J., Serruys P.W., and de Feyter P.J. Recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 26 (2005) 1070-1077
28. Eagle K.A., Guyton R.A., Davidoff R., Edwards F.H., Ewy G.A., Gardner T.J., Hart J.C., Hermann H.C., Hillis L.D., Hutter Jr. A.M., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. J Am Coll Cardiol 44 (2004) e213-e310
29. Thiele H., Sick P., Boudriot E., Diederich K.-W., Hambrecht R., Niebauer J., and Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 26 (2005) 1276-1283
30. Byrne J.G., Leacche M., Unic D., Rawn J.D., Simon D.I., Rogers C.D., and Cohn L.H. Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve disease. J Am Coll Cardiol 45 (2005) 14-18
31. Waksman R. Biodegradable stents: they do their job and disappear. J Invasive Cardiol 18 (2006) 70-74
32. Erbel R., Di Mario C., Bartunek J., Bonnier J., de Bruyne B., Eberli F.R., Erne P., Haude M., Heublein B., Horrigan M., et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 369 (2007) 1869-1875